Business Context and Reporting Period
Company: Envoy Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2024
Reporting Period: Not applicable (Event-based filing)
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market LLC under the symbols COCH (Class A Common Stock) and COCHW (Redeemable Warrants). This filing serves to furnish an updated Investor Presentation intended for use in meetings with current and potential investors.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of an attached presentation rather than a financial statement report.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The primary event is the distribution of an updated Investor Presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
- Forward-Looking Statements: The attached Investor Presentation contains forward-looking statements. Management directs readers to Page 2 of the presentation for a discussion of risks and uncertainties related to these statements.
- Legal Status of Information: The information in Item 7.01, including the Investor Presentation, is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Warrant Details: Redeemable Warrants (COCHW) are exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation) for specific financial data, strategic updates, and forward-looking guidance.
- Verify the risks and uncertainties detailed on Page 2 of the Investor Presentation.
- Confirm the current trading status and exercise terms of the COCHW warrants ($11.50 exercise price).
- Note that the content of this 8-K is not incorporated by reference into other SEC filings.